FDA Approved: MALARONE — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

The FDA approved a supplemental application for Malarone, a combination of atovaquone and proguanil hydrochloride, from GlaxoSmithKline LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)

Snippet

SUPPL AP for MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)